The Joe Rogan Experience

Joe Rogan Experience #1246 - Pot Debate - Alex Berenson & Dr. Michael Hart

Joe Rogan and Dr. Michael Hart on joe Rogan Moderates Fierce Cannabis Debate: Medicine, Madness, and Violence.

Joe RoganhostDr. Michael HartguestAlex BerensonguestJoe RoganhostAlex BerensonguestDr. Michael Hartguest
Feb 13, 20192h 48m
Is cannabis truly a medicine or primarily a recreational intoxicant?High-THC marijuana, psychosis, schizophrenia, and violence riskDifferences between THC and CBD, and their respective medical usesAdolescent brain development, early use, and mental health outcomesCannabis as a potential gateway drug vs. substitute for opioidsCrime and violence trends in legalization states and methodological disputesClinical vs. epidemiological evidence and bias in advocacy and research

In this episode of The Joe Rogan Experience, featuring Joe Rogan and Dr. Michael Hart, Joe Rogan Experience #1246 - Pot Debate - Alex Berenson & Dr. Michael Hart explores joe Rogan Moderates Fierce Cannabis Debate: Medicine, Madness, and Violence Joe Rogan hosts author Alex Berenson and cannabis physician Dr. Michael Hart for a deep, contentious discussion on whether marijuana is medicine or a dangerous neurotoxin. Berenson argues high-THC cannabis is largely a recreational drug that can trigger psychosis, schizophrenia, and violence in vulnerable users, and that legalization advocates underplay these risks. Hart counters with clinical experience and selected research showing benefits for pain, PTSD, seizures, cancer symptoms, TBI, and more, emphasizing CBD and careful medical guidance. The three also explore adolescent vulnerability, social media’s role in youth mental health, gateway-drug claims, crime statistics after legalization, and the ethics of how both sides present incomplete “truths.”

At a glance

WHAT IT’S REALLY ABOUT

Joe Rogan Moderates Fierce Cannabis Debate: Medicine, Madness, and Violence

  1. Joe Rogan hosts author Alex Berenson and cannabis physician Dr. Michael Hart for a deep, contentious discussion on whether marijuana is medicine or a dangerous neurotoxin. Berenson argues high-THC cannabis is largely a recreational drug that can trigger psychosis, schizophrenia, and violence in vulnerable users, and that legalization advocates underplay these risks. Hart counters with clinical experience and selected research showing benefits for pain, PTSD, seizures, cancer symptoms, TBI, and more, emphasizing CBD and careful medical guidance. The three also explore adolescent vulnerability, social media’s role in youth mental health, gateway-drug claims, crime statistics after legalization, and the ethics of how both sides present incomplete “truths.”

IDEAS WORTH REMEMBERING

7 ideas

Distinguish sharply between THC and CBD when discussing ‘marijuana.’

THC is psychoactive and linked to paranoia, cognitive changes, and potential psychosis in some users, while CBD is non-intoxicating and better supported for seizures, anxiety, and possibly PTSD and TBI; lumping them together distorts both risk and benefit profiles.

Adolescents and young adults are at significantly higher risk from high-THC use.

Both guests agree that using potent THC before roughly age 25—when the frontal lobe is still developing—raises concern for triggering or worsening psychotic disorders, with observational data linking early heavy use to schizophrenia-like outcomes in susceptible individuals.

Personal biology and genetics heavily shape cannabis responses.

Hart cites emerging genetic markers (e.g., MAPK14, AKT1, CADM2) that may predispose a minority of users (collectively ~15–20%) to adverse neurocognitive or psychotic reactions, underscoring that what is benign for one person can be destabilizing or disastrous for another.

Cannabis can be clinically useful, but current evidence is uneven and often preliminary.

There is solid evidence for CBD in childhood epilepsy and reasonable support for THC in chemotherapy nausea and appetite stimulation; other touted uses—PTSD, chronic pain, cancer, Alzheimer’s, TBI—rest on mixed or early-stage data, case reports, and clinician experience rather than robust randomized trials.

Psychosis and cannabis together can dramatically increase violence risk in a small subset.

Berenson argues, based on forensic psychiatry cases and limited studies, that cannabis-triggered or -worsened psychosis can amplify paranoid delusions and contribute to rare but severe violence, especially when combined with stimulants—though Hart counters that broad population-level links to crime remain weak.

Public messaging around cannabis has been highly one-sided in both directions.

Berenson admits his book is intentionally unbalanced toward harms, while Hart and Rogan point out legalization campaigns have long oversold benefits and minimized risks; all three ultimately agree users deserve full, nuanced information rather than advocacy-filtered narratives.

Social media and broader societal stressors complicate mental health attribution.

When discussing rising youth depression and suicide, Rogan and Hart highlight pressure from social media, bullying, and widening inequality, while Berenson focuses on cannabis use trends—illustrating how multiple concurrent factors make causal claims about marijuana and mental illness inherently difficult.

WORDS WORTH SAVING

5 quotes

This book is not balanced… I wrote a book that is trying to break through a lot of noise.

Alex Berenson

As a clinician, I go to bed every night knowing I killed zero people with cannabis.

Dr. Michael Hart

There are some people where cannabis is not a good idea… I’ve been guilty of pretending it’s benign for everyone.

Joe Rogan

Hope is not a substitute for science.

Alex Berenson

People shouldn’t be hearing just part of the truth; they should be hearing the whole truth.

Dr. Michael Hart

QUESTIONS ANSWERED IN THIS EPISODE

5 questions

How should medical and public-health authorities design cannabis warnings that are honest about both benefits and risks without veering into propaganda?

Joe Rogan hosts author Alex Berenson and cannabis physician Dr. Michael Hart for a deep, contentious discussion on whether marijuana is medicine or a dangerous neurotoxin. Berenson argues high-THC cannabis is largely a recreational drug that can trigger psychosis, schizophrenia, and violence in vulnerable users, and that legalization advocates underplay these risks. Hart counters with clinical experience and selected research showing benefits for pain, PTSD, seizures, cancer symptoms, TBI, and more, emphasizing CBD and careful medical guidance. The three also explore adolescent vulnerability, social media’s role in youth mental health, gateway-drug claims, crime statistics after legalization, and the ethics of how both sides present incomplete “truths.”

What kind of large, long-term studies would most convincingly clarify whether high-THC cannabis truly raises population rates of psychosis and violence?

Given adolescent brain vulnerability, what age limits, potency caps, or access controls make sense for legalized markets?

How can clinicians responsibly use cannabis as a tool for pain, PTSD, or opioid substitution while avoiding simply swapping one dependency for another?

To what extent are rising youth mental health problems driven by drugs like cannabis versus social media, economic precarity, and other cultural shifts—and how can we realistically untangle these factors?

EVERY SPOKEN WORD

Install uListen for AI-powered chat & search across the full episode — Get Full Transcript

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.

Add to Chrome